Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Studies support the use of INKP-102 as a novel purgative before colonoscopy

Nov. 3, 2005

D3 receptors validated as a target in gastric motility disorders

Nov. 3, 2005

MD-1100 demonstrates gastrointestinal activity in healthy volunteers

Nov. 2, 2005

Anti-HBV activity of ellagic acid

Nov. 2, 2005

Novel inhibitor of sphingolipid synthesis opens a new approach for anti-HCV drug design

Oct. 28, 2005

AT-1001 completes phase I study, receives fast track designation

Oct. 28, 2005

Enrollment completed in phase IIb HCV study of Albuferon plus ribavirin

Oct. 28, 2005

Novel treatment options for hepatic disorders described in recent patent literature

Oct. 26, 2005

Schering AG plans additional phase III Crohn's disease trial for sargramostim

Oct. 24, 2005

Polypill therapy may result promising for NAFLD

Oct. 21, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...